Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Toby M Maher

Showing results (281-290 of 307) with videos related to

Pageof 31
Sort By:
American Journal of Respiratory and Critical Care Medicine|December 19, 2023
Pulmonary Fibrosis Stakeholder Summit: A Joint NHLBI, Three Lakes Foundation, and Pulmonary Fibrosis Foundation Workshop ReportSydney B Montesi, Christian R Gomez, Michael Beers, et al.
American Journal of Respiratory and Critical Care Medicine|January 4, 2024
Meaningful Endpoints for Idiopathic Pulmonary Fibrosis (IPF) Clinical Trials: Emphasis on 'Feels, Functions, Survives'. Report of a Collaborative Discussion in a Symposium with Direct Engagement from Representatives of Patients, Investigators, the National Institutes of Health, a Patient Advocacy Organization, and a Regulatory AgencyGanesh Raghu, Marya Ghazipura, Thomas R Fleming, et al.
American Journal of Respiratory and Critical Care Medicine|June 27, 2019
Diagnostic Likelihood Thresholds That Define a Working Diagnosis of Idiopathic Pulmonary FibrosisSimon L F Walsh, David J Lederer, Christopher J Ryerson, et al.
Matrix Biology : Journal of the International Society for Matrix Biology|June 13, 2024
The fibroblast hormone Endotrophin is a biomarker of mortality in chronic diseasesFederica Genovese, Cecilie Bager, Peder Frederiksen, et al.
The European Respiratory Journal|September 2, 2017
Diagnostic accuracy of a clinical diagnosis of idiopathic pulmonary fibrosis: an international case-cohort studySimon L F Walsh, Toby M Maher, Martin Kolb, et al.
The Lancet. Respiratory Medicine|September 2, 2018
Effect of ambulatory oxygen on quality of life for patients with fibrotic lung disease (AmbOx): a prospective, open-label, mixed-method, crossover randomised controlled trialDina Visca, Letizia Mori, Vicky Tsipouri, et al.
American Journal of Respiratory and Critical Care Medicine|May 5, 2026
A statistical Model for Lung Function Trajectory and Mortality in Patients with Fibrotic Interstitial Lung DiseaseBarbara Wendelberger, Thomas P Jensen, Melanie Quintana, et al.
American Journal of Respiratory and Critical Care Medicine|April 29, 2022
Idiopathic Pulmonary Fibrosis (an Update) and Progressive Pulmonary Fibrosis in Adults: An Official ATS/ERS/JRS/ALAT Clinical Practice GuidelineGanesh Raghu, Martine Remy-Jardin, Luca Richeldi, et al.
American Journal of Respiratory and Critical Care Medicine|July 14, 2026
Acute exacerbation in fibrotic interstitial lung disease: An International Working Group ReportYet H Khor, Fabrizio Luppi, Ayodeji Adegunsoye, et al.
American Journal of Respiratory and Critical Care Medicine|March 30, 2022
Integrating Clinical Probability into the Diagnostic Approach to Idiopathic Pulmonary Fibrosis: An International Working Group PerspectiveVincent Cottin, Sara Tomassetti, Claudia Valenzuela, et al.
Pageof 31

Showing results (281-290 of 307) with videos related to

Sort By:
Pageof 31
American Journal of Respiratory and Critical Care Medicine|December 19, 2023
Pulmonary Fibrosis Stakeholder Summit: A Joint NHLBI, Three Lakes Foundation, and Pulmonary Fibrosis Foundation Workshop ReportSydney B Montesi, Christian R Gomez, Michael Beers, et al.
American Journal of Respiratory and Critical Care Medicine|January 4, 2024
Meaningful Endpoints for Idiopathic Pulmonary Fibrosis (IPF) Clinical Trials: Emphasis on 'Feels, Functions, Survives'. Report of a Collaborative Discussion in a Symposium with Direct Engagement from Representatives of Patients, Investigators, the National Institutes of Health, a Patient Advocacy Organization, and a Regulatory AgencyGanesh Raghu, Marya Ghazipura, Thomas R Fleming, et al.
American Journal of Respiratory and Critical Care Medicine|June 27, 2019
Diagnostic Likelihood Thresholds That Define a Working Diagnosis of Idiopathic Pulmonary FibrosisSimon L F Walsh, David J Lederer, Christopher J Ryerson, et al.
Matrix Biology : Journal of the International Society for Matrix Biology|June 13, 2024
The fibroblast hormone Endotrophin is a biomarker of mortality in chronic diseasesFederica Genovese, Cecilie Bager, Peder Frederiksen, et al.
The European Respiratory Journal|September 2, 2017
Diagnostic accuracy of a clinical diagnosis of idiopathic pulmonary fibrosis: an international case-cohort studySimon L F Walsh, Toby M Maher, Martin Kolb, et al.
The Lancet. Respiratory Medicine|September 2, 2018
Effect of ambulatory oxygen on quality of life for patients with fibrotic lung disease (AmbOx): a prospective, open-label, mixed-method, crossover randomised controlled trialDina Visca, Letizia Mori, Vicky Tsipouri, et al.
American Journal of Respiratory and Critical Care Medicine|May 5, 2026
A statistical Model for Lung Function Trajectory and Mortality in Patients with Fibrotic Interstitial Lung DiseaseBarbara Wendelberger, Thomas P Jensen, Melanie Quintana, et al.
American Journal of Respiratory and Critical Care Medicine|April 29, 2022
Idiopathic Pulmonary Fibrosis (an Update) and Progressive Pulmonary Fibrosis in Adults: An Official ATS/ERS/JRS/ALAT Clinical Practice GuidelineGanesh Raghu, Martine Remy-Jardin, Luca Richeldi, et al.
American Journal of Respiratory and Critical Care Medicine|July 14, 2026
Acute exacerbation in fibrotic interstitial lung disease: An International Working Group ReportYet H Khor, Fabrizio Luppi, Ayodeji Adegunsoye, et al.
American Journal of Respiratory and Critical Care Medicine|March 30, 2022
Integrating Clinical Probability into the Diagnostic Approach to Idiopathic Pulmonary Fibrosis: An International Working Group PerspectiveVincent Cottin, Sara Tomassetti, Claudia Valenzuela, et al.
Pageof 31